Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats

European Journal of Pharmacology

Volumn 562, Issue 3, 2007, Pages 198-207

  Goñi Allo, Beatriz ^a   Puerta, Elena ^a   Hervias, Isabel ^a   Di Palma, Richard ^a   Ramos, Maria ^a   Lasheras, Berta ^a   Aguirre, Norberto ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

3,4 Methylenedioxymethamphetamine (MDMA, "ecstasy"); 5 Hydroxytryptamine (5 HT, serotonin); Amiloride; Hyperthermia; Neurotoxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 (N,N DIMETHYL)AMILORIDE; AMILORIDE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FLUNARIZINE; FLUOXETINE; METHAMPHETAMINE; SEROTONIN; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; FRONTAL CORTEX; HIPPOCAMPUS; HYPERTHERMIA; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

AMILORIDE; ANIMALS; BODY TEMPERATURE; CORPUS STRIATUM; DRUG SYNERGISM; FEVER; HALLUCINOGENS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGENTS; SODIUM CHANNEL BLOCKERS; SODIUM-HYDROGEN ANTIPORTER;

EID: 34147122755     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.049     Document Type: Article

References (53)

1. 1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion. Eur. J. Pharmacol. 346 (1998) 181-188
2. Aguirre N., Barrionuevo M., Ramirez M.J., Del Rio J., and Lasheras B. Alpha-lipoic acid prevents 3,4-Methylenedioxymethamphetamine (MDMA)-induced neurotoxicity. NeuroReport 10 (1999) 3675-3680
3. 1A receptors in rats. Eur. J. Pharmacol. 281 (1995) 101-105
4. Bai F., Lau S.S., and Monks T.J. Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity. Chem. Res. Toxicol. 12 (1999) 1150-1157
5. Broening H.W., Bowyer J.F., and Slikker Jr. W. Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J. Pharmacol. Exp. Ther. 275 (1995) 325-333
6. 2+ exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity. J. Neurochem. 77 (2001) 1348-1361
7. Darvesh A.S., and Gudelsky G.A. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Brain Res. 1056 (2005) 168-175
8. Esteban E., O'Shea E., Camarero J., Sanchez V., Green A.R., and Colado M.I. 3,4-methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154 (2001) 251-260
9. Farfel G.M., and Seiden L.S. Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J. Pharmacol. Exp. Ther. 272 (1995) 860-867
10. Finnegan K.T., Calder L., Clikeman J., Wei S., and Karler R. Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats. Brain Res. 603 (1993) 134-138
11. Globus M.Y., Busto R., Lin B., Schnippering H., and Ginsberg M.D. Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J. Neurochem. 65 (1995) 1250-1256
12. Green A.R., Mechan A.O., Elliot J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 55 (2003) 463-508
13. Green A.R., O'Shea E., and Colado M.I. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur. J. Pharmacol. 500 (2004) 3-13
14. Guldesky G.A. Effect of ascorbate and cysteine on the methylendioxymethamphetamine-induced depletion on brain serotonin. J. Neural Transm. 103 (1996) 1397-1404
15. Hatzdimitrou G., McCann U.D., and Ricaurte G.A. Altered serotonin innervation patterns in the forebrain of monkeys with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J. Neurosci. 19 (1999) 5096-5107
16. Hatzdimitrou G., Tsai E.H., McCann U.D., and Ricaurte G.A. Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine. Synapse 44 (2002) 51-57
17. Hervias I., Lasheras B., and Aguirre N. 2-Deoxy-d-Glugose prevents and nicotinamide potentiates 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity. J. Neurochem. 75 (2000) 982-990
18. Hiramatsu M., Kumagai Y., Unger S.E., and Cho A.K. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and quinone identified as its glutathione adduct. J. Pharmacol. Exp. Ther. 254 (1990) 521-528
19. Holmes B., Brogden R.N., Heel R.C., and Speight T.M. Avery GS. Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 27 (1984) 6-44
20. Johnson M., Mitros K., Stone D.M., Zobrist R., Hanson G.R., and Gibb J.W. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 261 (1992) 586-591
21. Jones D.C., Duvauchelle C., Olsen C.M., Lau S.S., de la Torre R., and Monks T.J. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain. J. Pharmacol. Exp. Ther. 313 (2005) 422-431
22. Jones D.C., Lau S.S., and Monks T.J. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells. J. Pharmacol. Exp. Ther. 311 (2004) 298-306
23. Kil H.Y., Zhang J., and Piantadosi C.A. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J. Cereb. Blood Flow Metab. 16 (1996) 100-106
24. Kish S.J., Furukawa Y., Ang L., Vorce S.P., and Kalasinsky K.S. Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user. Neurology 55 (2000) 294-296
25. Kitai R., Kabuto M., Kubota T., Kobayashi H., Matsumoto H., Hayashi S., Shioura H., Ohtsubo T., Katayama K., and Kano E. Sensitization to hyperthermia by intracellular acidification of C6 glioma cells. J. Neuro-oncol. 39 (1998) 197-203
26. Kleyman T.R., and Cragoe Jr. E.J. Amiloride and its analogs as tools in the study of ion transport. J. Membr. Biol. 105 (1988) 1-21
27. LaVoie M.J., and Hastings T.G. Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. J. Neurochem. 73 (1999) 2546-2554
28. Lesch K.P., Heils A., and Riederer P. The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes. J. Mol. Med. 74 (1996) 365-378
29. Li J.H., and Liu F.F. Intracellular pH and heat sensitivity in two human cancer cell lines. Radiother. Oncol. 42 (1997) 69-76
30. Lyons J.C., Kim G.E., and Song C.W. Modification of intracellular pH and thermosensitivity. Radiat. Res. 129 (1992) 79-87
31. Malberg J.E., Sabol K.E., and Seiden L.S. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J. Pharmacol. Exp. Ther. 278 (1996) 258-267
32. Malberg J.E., and Seiden L.S. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J. Neurosci. 18 (1998) 5086-5094
33. 3H]-hydroxytryptamine uptake in rat diencephalon. J. Neurochem. 59 (1992) 1856-1861
34. McCann U.D., Szabo Z., Scheffel U., Dannals R.F., and Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 352 (1998) 1433-1437
35. Miller D.B., and O'Callaghan J.P. Elevated environmental temperature and methamphetamine neurotoxicity. Environ. Res. 92 (2003) 48-53
36. Monks T.J., Jones D.C., Bai F., and Lau S.S. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity. Ther. Drug Monit. 26 (2004) 132-136
37. Nixdorf W.L., Burrows K.B., Gudelsky G.A., and Yamamoto B.K. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate. J. Neurochem. 77 (2001) 647-654
38. O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., and Molliver M.E. Methylenedioxyamphetamine (MDA) and Methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: Inmunocytochemical evidence for neurotoxicity. J. Neurosci. 8 (1988) 2788-2803
39. Paxinos G., and Watson C. The Rat Brain in Sterotaxic Coordinates (1997), Academic Press, San Diego
40. Perez-Otano I., Herrero M.T., Oset C., De Ceballos M.L., Luquin M.R., Obeso J.A., and Del Río J. Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset. Brain Res. 567 (1991) 127-132
41. Ricaurte G.A., Yuan J., and McCann U.D. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42 (2000) 5-10
42. Rothman R.B., and Bauman M.H. Therapeutic and adverse actions of serotonin transporter substrates. Pharmacol. Ther. 95 (2002) 73-88
43. Rudnick G., and Wall S.C. The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1817-1821
44. Sanchez V., O'Shea E., Saadat K.S., Elliott J.M., Colado M.I., and Green A.R. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones. J. Psychopharmacol. 8 (2004) 412-416
45. Schmidt C.J., Black C.K., Abbate G.M., and Taylor V.L. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors. Brain Res. 529 (1990) 85-90
46. Shankaran M., Yamamoto B.K., and Gudelsky G.A. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum. J. Neurochem. 72 (1999) 2516-2522
47. Shankaran M., Yamamoto B.K., and Gudelsky G.A. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse 40 (2001) 55-64
48. Song C.W., Lyons J.C., Makepeace C.M., Griffin R.J., and Cragoe Jr. E.J. Effects of HMA, an analog of amiloride, on the thermosensitivity of tumors in vivo. Int. J. Radiat. Oncol. Biol. Phys. 30 (1994) 133-139
49. Sprague J.E., Everman S.L., and Nichols D.E. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 19 (1998) 427-441
50. Stone D.M., Johnson M., Hanson G.R., and Gibb J.W. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 247 (1998) 79-87
51. + exchange system. Mol. Pharmacol. 25 (1984) 131-136
52. Yeh S.Y., Dersch C., Rothman R., and Cadet J.L. Effects of antihistamines on 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats. Synapse 33 (1999) 207-217
53. Ying W., Han S.K., Miller J.W., and Swanson R.A. Acidosis potentiates oxidative neuronal death by multiple mechanisms. J. Neurochem. 73 (1999) 1549-5156